Capitol Hill’s coronavirus response delays drug pricing legislation

Capitol Hill’s coronavirus response delays drug pricing legislation

STAT Plus: Lawmakers’ coronavirus response means delays for drug pricing legislation

By LEV FACHER

SUSAN WALSH/AP

Lawmakers, lobbyists, and drug pricing advocates saw May as a final opportunity this year to pass drug pricing legislation.

READ MORE